ALLAN JONATHAN (GENERAL COUNSEL & CORP SEC) sold 32.2% of their position (9.29K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $313.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/24/2026ACC: 0001966716-26-000008
Officer· GENERAL COUNSEL & CORP SEC
Since Feb 2026
-9.29K
Net shares
Net seller
$313.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.69K
Price / share
$33.64
Trade value
$292.36K
% of position
30.1%
3/20/2026
28.84K→20.14K
Common Stock
Direct
Shares
−601.00
Price / share
$34.41
Trade value
$20.68K
% of position
3.0%
3/20/2026
20.14K→19.54K
Total
Net shares
−9.29K
Net value
-$313.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | S · Sale | −8.69K | $33.64 | $292.36K | 30.1% | 28.84K | 20.14K |
| Common Stock Direct | 3/20/2026 | S · Sale | −601.00 | $34.41 | $20.68K | 3.0% | 20.14K | 19.54K |
| Total | −9.29K | -$313.04K | ||||||
Derivative Transactions0
No derivative transactions reported